Good day. It remains to be seen whether the conviction of Theranos Inc. founder Elizabeth Holmes on conspiracy and fraud charges will have ramifications for startup investing. Are the findings a strike against Silicon Valley startup culture that will prompt investors to rethink due diligence and founders to scale back claims about their technology? Or is the case an outlier that investors will largely brush aside as they commit record amounts of capital to largely unproven companies?
Meanwhile, innovation in blood testing…